Eric Cambern Wooten, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Disulfide-Isomerases | 1 | 2010 | 207 | 0.300 |
Why?
|
Aneuploidy | 2 | 2024 | 551 | 0.290 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1133 | 0.290 |
Why?
|
Data Mining | 1 | 2011 | 551 | 0.260 |
Why?
|
Databases, Genetic | 1 | 2011 | 1737 | 0.230 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1309 | 0.220 |
Why?
|
Haplotypes | 1 | 2010 | 2764 | 0.220 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2022 | 1765 | 0.200 |
Why?
|
GATA4 Transcription Factor | 1 | 2022 | 124 | 0.190 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1740 | 0.190 |
Why?
|
Aortic Valve | 2 | 2011 | 1950 | 0.180 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2825 | 0.180 |
Why?
|
Antigens, CD | 1 | 2010 | 3997 | 0.160 |
Why?
|
Repressor Proteins | 1 | 2010 | 2980 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2012 | 15773 | 0.150 |
Why?
|
Biological Transport | 1 | 2022 | 2084 | 0.140 |
Why?
|
Loss of Heterozygosity | 1 | 1999 | 659 | 0.140 |
Why?
|
Receptors, Notch | 2 | 2024 | 743 | 0.120 |
Why?
|
Astrocytoma | 1 | 1999 | 775 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 370 | 0.110 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4673 | 0.110 |
Why?
|
DNA Copy Number Variations | 2 | 2024 | 2012 | 0.110 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2012 | 246 | 0.100 |
Why?
|
Myoblasts | 1 | 2013 | 232 | 0.100 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1086 | 0.090 |
Why?
|
Taxoids | 2 | 2005 | 668 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2005 | 623 | 0.090 |
Why?
|
Genetic Markers | 2 | 2011 | 2608 | 0.090 |
Why?
|
Introns | 1 | 2012 | 978 | 0.090 |
Why?
|
Glucuronidase | 1 | 2011 | 202 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2010 | 3774 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2022 | 8506 | 0.080 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2008 | 128 | 0.070 |
Why?
|
Neoplasms | 4 | 2024 | 22032 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2858 | 0.070 |
Why?
|
Ethanol | 1 | 2013 | 1323 | 0.070 |
Why?
|
Triiodothyronine | 1 | 2008 | 493 | 0.070 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1996 | 0.070 |
Why?
|
Models, Animal | 1 | 2011 | 2112 | 0.060 |
Why?
|
Glioblastoma | 1 | 1999 | 3480 | 0.060 |
Why?
|
Brachytherapy | 1 | 2011 | 1236 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2012 | 22029 | 0.050 |
Why?
|
Heart Valve Diseases | 1 | 2011 | 1033 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2717 | 0.050 |
Why?
|
Signal Transduction | 3 | 2016 | 23342 | 0.050 |
Why?
|
Mitral Valve | 1 | 2011 | 1466 | 0.050 |
Why?
|
Gene Expression Profiling | 4 | 2013 | 9404 | 0.050 |
Why?
|
Artifacts | 1 | 2011 | 1897 | 0.050 |
Why?
|
Drosophila melanogaster | 1 | 2011 | 1710 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12436 | 0.050 |
Why?
|
Germ Layers | 1 | 2021 | 71 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2021 | 11471 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2011 | 12604 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2018 | 4624 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2024 | 10416 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17617 | 0.040 |
Why?
|
Zebrafish | 1 | 2011 | 2993 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 2022 | 604 | 0.040 |
Why?
|
Organ Specificity | 1 | 2024 | 1955 | 0.040 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21017 | 0.040 |
Why?
|
Homeodomain Proteins | 2 | 2022 | 2413 | 0.040 |
Why?
|
Immune Evasion | 1 | 2022 | 362 | 0.040 |
Why?
|
Translocation, Genetic | 1 | 2024 | 1387 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 1999 | 8981 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 178 | 0.040 |
Why?
|
Myocytes, Cardiac | 2 | 2022 | 1655 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 1999 | 442 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6852 | 0.030 |
Why?
|
Keratins | 1 | 2018 | 497 | 0.030 |
Why?
|
Genotype | 1 | 2011 | 12945 | 0.030 |
Why?
|
Phenotype | 2 | 2011 | 16534 | 0.030 |
Why?
|
Paclitaxel | 1 | 2003 | 1728 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 402 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2024 | 1885 | 0.030 |
Why?
|
Humans | 15 | 2024 | 758406 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1059 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 575 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2003 | 2433 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2018 | 814 | 0.030 |
Why?
|
Animals | 7 | 2022 | 167768 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2021 | 1262 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 1999 | 1745 | 0.030 |
Why?
|
Myogenin | 1 | 2013 | 55 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1825 | 0.030 |
Why?
|
Mice | 6 | 2022 | 81101 | 0.030 |
Why?
|
Ribosomes | 1 | 2016 | 501 | 0.030 |
Why?
|
MyoD Protein | 1 | 2013 | 142 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1351 | 0.030 |
Why?
|
Cell Fusion | 1 | 2013 | 293 | 0.030 |
Why?
|
Cohort Studies | 2 | 2012 | 41256 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2626 | 0.030 |
Why?
|
Lipids | 1 | 2003 | 3326 | 0.030 |
Why?
|
Iridium Radioisotopes | 1 | 2011 | 26 | 0.030 |
Why?
|
Cell Shape | 1 | 2013 | 371 | 0.030 |
Why?
|
Oncogenes | 1 | 2018 | 1220 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2024 | 3664 | 0.020 |
Why?
|
Point Mutation | 1 | 2017 | 1593 | 0.020 |
Why?
|
Genomics | 2 | 2018 | 5790 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9574 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2013 | 7590 | 0.020 |
Why?
|
Cell Line | 2 | 2008 | 15591 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1312 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2013 | 540 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2005 | 5249 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6068 | 0.020 |
Why?
|
RNA Interference | 1 | 2018 | 2836 | 0.020 |
Why?
|
Breast | 2 | 2011 | 1963 | 0.020 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2008 | 13 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3432 | 0.020 |
Why?
|
Transcription Factors | 1 | 2008 | 12094 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2930 | 0.020 |
Why?
|
Mice, Inbred ICR | 1 | 2008 | 364 | 0.020 |
Why?
|
Female | 7 | 2024 | 390323 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 933 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4257 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1136 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1791 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 2011 | 972 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2904 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 58808 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 796 | 0.020 |
Why?
|
Middle Aged | 4 | 2012 | 219568 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2011 | 1182 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 1096 | 0.010 |
Why?
|
Adult | 4 | 2012 | 219935 | 0.010 |
Why?
|
Heart Failure | 1 | 2008 | 11593 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22003 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9985 | 0.010 |
Why?
|
Melanoma | 1 | 2022 | 5691 | 0.010 |
Why?
|
Electron Transport | 1 | 2003 | 206 | 0.010 |
Why?
|
Neoadjuvant Therapy | 2 | 2005 | 2821 | 0.010 |
Why?
|
Lipolysis | 1 | 2003 | 209 | 0.010 |
Why?
|
Citric Acid Cycle | 1 | 2003 | 230 | 0.010 |
Why?
|
Calcinosis | 1 | 2011 | 1467 | 0.010 |
Why?
|
Disease Progression | 1 | 1999 | 13468 | 0.010 |
Why?
|
Genes, Neoplasm | 1 | 2003 | 370 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16886 | 0.010 |
Why?
|
Obesity | 1 | 2003 | 12870 | 0.010 |
Why?
|
Immunotherapy | 1 | 2017 | 4641 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5199 | 0.010 |
Why?
|
Prognosis | 2 | 2017 | 29557 | 0.010 |
Why?
|
Kidney | 2 | 2008 | 7016 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9460 | 0.010 |
Why?
|
Transfection | 1 | 2008 | 5779 | 0.010 |
Why?
|
Male | 3 | 2012 | 358747 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1630 | 0.010 |
Why?
|
Skin | 1 | 2011 | 4464 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2003 | 2221 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5779 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11152 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2008 | 1944 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2005 | 3527 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4567 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9518 | 0.010 |
Why?
|
Echocardiography | 1 | 2008 | 4962 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29915 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23679 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2003 | 3299 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2011 | 64378 | 0.010 |
Why?
|
Myocardium | 1 | 2003 | 4690 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2003 | 4938 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2003 | 14354 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7502 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2011 | 58683 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 11892 | 0.000 |
Why?
|
Aged | 1 | 2011 | 168218 | 0.000 |
Why?
|